Literature DB >> 2837210

Reduction in tumor necrosis factor receptor affinity and cytotoxicity by glucocorticoids.

F C Kull1.   

Abstract

Micromolar concentrations of glucocorticoids rendered L-M cells (a murine tumorigenic fibroblast line) less sensitive to the cytotoxic activity of murine TNF. The potency of different steroids paralleled their known anti-inflammatory potency, and pretreatment was more effective than post treatment. Sex steroids and mineralocorticoids were ineffective. Dexamethasone also decreased the sensitivity of MCF-7 (a human mammary carcinoma line) to the cytotoxic activity of human recombinant TNF. Pretreatment of both cell lines reduced the affinity of specific cell surface receptors for the binding of their species 125I-TNF about 3-fold while retaining the same number of binding sites. The decrease in sensitivity was not due solely to the inhibition of early TNF-induced events (such as binding, internalization or signal transduction). Dexamethasone modestly enhanced inhibition beyond that of neutralizing antiserum alone when both were added midway in the L-M killing reaction (after receptor down regulation but before the onset of complete cell death).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837210     DOI: 10.1016/s0006-291x(88)81238-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Dexamethasone inhibits TNF-alpha-induced apoptosis and IAP protein downregulation in MCF-7 cells.

Authors:  U K Messmer; C Pereda-Fernandez; M Manderscheid; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Suppression of apoptosis by glucocorticoids in glomerular endothelial cells: effects on proapoptotic pathways.

Authors:  U K Messmer; G Winkel; V A Briner; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells.

Authors:  L Snyers; L De Wit; J Content
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Progesterone antagonizes the permissive action of estradiol on tumor necrosis factor-alpha-induced apoptosis of anterior pituitary cells.

Authors:  M Candolfi; G Jaita; V Zaldivar; S Zárate; L Ferrari; D Pisera; M G Castro; A Seilicovich
Journal:  Endocrinology       Date:  2004-11-04       Impact factor: 4.736

5.  Modulation of tumor necrosis factor (TNF) receptor expression during monocytic differentiation by glucocorticoids.

Authors:  M Goppelt-Struebe; C O Reiser; N Schneider; M Grell
Journal:  Inflamm Res       Date:  1996-10       Impact factor: 4.575

6.  Effects of n-3 and n-6 fatty acids on tumor necrosis factor cytotoxicity in WEHI fibrosarcoma cells.

Authors:  O L Brekke; T Espevik; T Bardal; K S Bjerve
Journal:  Lipids       Date:  1992-03       Impact factor: 1.880

7.  Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.

Authors:  M Costas; T Trapp; M P Pereda; J Sauer; R Rupprecht; V E Nahmod; J M Reul; F Holsboer; E Arzt
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release.

Authors:  O L Brekke; T Espevik; K S Bjerve
Journal:  Lipids       Date:  1994-02       Impact factor: 1.880

9.  Interleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids.

Authors:  M T Vogels; C G Sweep; A R Hermus; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 10.  Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence.

Authors:  Eri Shirakami; Sho Yamakawa; Kenji Hayashida
Journal:  Burns Trauma       Date:  2020-01-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.